-
Acquisition of Cytokine
-Acquisition of Cytokine PharmaSciences Inc. (CPSI) and its subsidiary, Controlled Therapeutics Scotland (CTS). The new entity called Ferring Controlled Therapeutics…
0 -
Ferring celebrated its 60th anniversary
-Ferring was founded in 1950 and celebrated its 60th anniversary in 2010. The company has evolved from a small 2-people…
-
Launch of FIRMAGON
-Launch of FIRMAGON® (degarelix), a GnRH blocker for advanced hormone-dependent prostate cancer.
-
Ferring Headquarters open
-Ferring Headquarters and new production facility open in Saint-Prex, Switzerland. The facility provides additional production capacity for Ferring’s dry products…
-
Starting signal for Ferring’s fifth production site
-Ferring breaks the ground for the building of its new state-of-the-art multi-purpose site in Saint-Prex, Switzerland and thereby continues its…
-
Ferring International Center opens for business
-On January 1st the new Ferring International Center building in Ørestad, Copenhagen opened for business. With its 20 floors, designed…
-
Launch of TRACTOCILE
-In 2000, Ferring launched its latest medicine, TRACTOCILE® (atosiban), a new chemical entity developed by Ferring’s researchers for the treatment…
-
Ferring’s founder dies at 88
-Dr. Frederik Paulsen, Ferring’s founder, died at the age of 88, after having spent his last 17 years on his…
-
Launch of ZOMACTON
-Ferring launched ZOMACTON® (hGH) for the treatment of growth hormone deficiency (GHD) in children and for the treatment of girls…
-
Winter School
-Ferring became the main sponsor of the ESPE (European Society for Paediatric Endocrinology) Winter School for young paediatric endocrinologists from…
TIMELINES
TIMELINES